Email
Print
qPCR Reagents Market Overview
qPCR Reagents Market size is estimated to reach $2,932 million
by 2026, growing at a CAGR of 7.7% during the forecast period 2021-2026. Quantitative
PCR (q PCR) Reagents utilize the linearity of DNA amplification to conclude
absolute or relative quantities of a recognized sequence in a sample. qPCR (Quantitative
Polymerase Chain Reaction) indicates real-time polymerase chain reaction or
quantitative PCR, which permits concurrent amplification and detection of DNA
in real-time. Quantitative polymerase chain reaction (qPCR) is a technique by
which the quantity of the PCR product may be established, in real-time, and is
very beneficial for examining gene expression. Quantitative PCR, irrespective
of including a reverse transcription step or not, is conventionally utilized in
molecular biology laboratories.
The increasing population of senior citizens is set to drive
the qPCR Reagents Market owing to the boost in demand for genetic tests which
may involve real-time polymerase chain reactions. The surge in the count of
genome projects needing gene sequencing and genetic tests to comprehend the
human gene sequence is set to propel the growth of the qPCR Reagents Market
during the forecast period 2021-2026. This represents the qPCR Reagents Industry
Outlook.
Report Coverage
The report: “qPCR Reagents Market
Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis
of the following segments of the qPCR Reagents Market.
By Detection Method: Dye-Based
qPCR Reagents, Probes & Primer-Based qPCR Reagents.
By Packaging Type: qPCR Core
Kits, qPCR Mastermixes.
By Application: Diagnostic, Research,
Forensic.
By End User: Hospitals and Diagnostic Centers,
Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology
Companies, Clinical Research Organizations (CROs), Forensic Laboratories.
By Geography: North America (the U.S, Canada, and Mexico),
Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe),
Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand,
and Rest of Asia-Pacific), South America (Brazil, Argentina, Rest of South
America) and Rest Of The World (Middle East, Africa).
Key Takeaways
- Geographically, North America qPCR Reagents Market accounted for the highest revenue share in 2020 and it is poised to dominate the market over the period 2021-2026 owing to the increasing predominance of cancer and infectious ailments involving real-time polymerase chain reaction in the North American region resulting in heightening demand for qPCR reagents.
- qPCR Reagents Market growth is being driven by the growing occurrences of genetic ailments requiring real-time polymerase chain reaction and resulting in a boost in demand for diagnostic tests enabling people to take precautionary actions. However, the soaring cost of qPCR machinery and dearth of great technical competence to handle qPCR machinery is one of the major factors hampering the growth of the qPCR Reagents Market.
- qPCR Reagents Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the qPCR Reagents Market report.
qPCR Reagents Market Share, By Detection Method, 2020(%)
For More Details on This Report - Request for Sample
qPCR Reagents Market Segment Analysis – By Detection Method:
The qPCR Reagents Market based on detection
method can be further segmented into Dye-Based qPCR Reagents and Probes &
Primer-Based qPCR Reagents.
The Dye-Based qPCR Reagents Segment held the largest market share in 2020. This growth is
owing to the increased application of fluorescent DNA-binding dyes in the
supervision of DNA Synthesis. qPCR involves a real-time polymerase chain
reaction. The characteristic of increasing fluorescence of dyes with the
existence of double-stranded DNA is further propelling the growth of this
segment.
Furthermore, the Dye-Based qPCR Reagents segment is estimated to grow with the fastest CAGR of 8.2% during the forecast period 2021-2026 owing to the extensive application of dye-based diagnostic qualitative PCR for the accelerated diagnostic discovery of nucleic acids indicative of infectious ailments, cancer, and genetic abnormalities which may involve real-time polymerase chain reaction.
qPCR
Reagents Market Segment Analysis – By Packaging Type:
The qPCR Reagents Market
based on packaging type can be further segmented into qPCR Core Kits
and qPCR Mastermixes. The qPCR
Core Kits Segment held the
largest market share in 2020. This growth is
owing to the increased affordability of core kits which are available at
lesser prices in comparison with qPCR Mastermixes.
qPCR involves a real-time polymerase chain reaction. The
increased flexibility offered to end-users is further propelling the growth of
this segment owing to its suitability for building independent response
protocols by researchers.
Furthermore, the qPCR
Mastermixes segment is estimated to grow with the
fastest CAGR of 8.4% during the forecast period 2021-2026 owing to the surging
availability of optimized MasterMixes like Canvax™ qMAXSen™ products which are
inclusive of all the constituents for a real-time polymerase chain reaction, except sample DNA and Primers and provide a
phenomenal Sensitivity and Performance for the two most utilized qPCR techniques
termed intercalating Green Dyes based or Probe-based assays.
qPCR Reagents Market Segment
Analysis – By Geography:
The qPCR Reagents Market
based on geography can be further segmented into North America, Europe,
Asia-Pacific, South America, and the Rest of the World. North America (qPCR Reagents
Market) held the largest share with 33% of the overall market in 2020. The growth
of this region is owing to the well-established healthcare system and the soaring
concentration of key players like Takara Bio in the region. The increased
impetus for research and development in conjunction with increased demand for qPCR diagnostic tests involving real-time polymerase chain
reaction is further fueling the growth of the qPCR Reagents Market in the
North-American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2021-2026. This growth is owing to factors like the increasing population of the elderly and the altering patterns of healthcare spending. The increasing birth rate, the heightening count of clinical laboratories, and the soaring acceptance of qPCR Reagents involving real-time polymerase chain reaction in Forensics are fuelling the progress of the qPCR Reagents Market in the Asia-Pacific region.
qPCR Reagents Market Drivers
Global Prevalence Of Incessant Ailments Is Projected To Drive The Growth Of qPCR Reagents Market:
Technological Innovations Are Expected To Boost The Demand Of qPCR Reagents:
Technological innovations are driving the growth of the qPCR Reagents market.
The AriaMx Real-time PCR (Real-Time Polymerase Chain Reaction) System developed
by Agilent is a completely combined quantitative PCR amplification, discovery,
and data analysis system. The AriaMx amplifies the output with its rare modular
and malleable design, instinctive touch-screen interface, progressive, effortless
reporting, and 120+ attributes supervised by way of the built-in onboard
diagnostics to assist in locating assay or instrument issues as they come up. The
real-time PCR (Real-Time Polymerase Chain Reaction) specialty kits and reagents
developed by Agilent are quick, effective, and deliver great specificity These
kinds of technological innovations are driving the growth of the qPCR Reagents Market
during the forecast period 2021-2026.
qPCR Reagents Market Challenges
Limitations Of Real-Time PCR Are Challenging The qPCR Reagents Market:
Real-Time Polymerase Chain Reaction has limitations like PCR product rises exponentially and it is not
possible to supervise the amplicon size. There is a boost in variation with cycle
number. An utmost of four concurrent reactions can be considered. There is an overlap of emission spectra. There is an expanded hazard of a false negative in
pathogen detection, specifically for novel emerging or greatly variable
pathogens. Non-specific binding is observed in SYBR green analysis. These are
the disadvantages of Real-Time Polymerase Chain Reaction which are hampering
the growth of the qPCR Reagents Market. Furthermore, the utilization of the qPCR procedure
is unregulated worldwide, which has made end-users hesitant to utilize qPCR
products in genomic analysis and ailments diagnosis which is further
challenging the qPCR Reagents Market.
qPCR Reagents Market - Landscape
Product commercialization, greater funds for research, superior distribution systems, agreements, geographic expansion, collaborations, and awareness campaigns are key strategies adopted by players in the qPCR Reagents Market. Key companies of this market include:
- F. Hoffman-La Roche Ltd.
- Bio-Rad Laboratories Inc
- Sigma-Aldrich Corporation (Merck Kgaa)
- Agilent Technologies Inc.
- Thermo Fischer Scientific Inc
- Qiagen N.V.
- Takara Bio
- Affymetrix Inc.
- Promega Corporation
- Quanta Biosciences
Acquisitions/Product Launches:
- In October 2021, Roche introduced the AVENIO Tumor Tissue CGP Kit. The Kit supplements the present CGP portfolio provided by Roche and Foundation Medicine and permits laboratories to augment their oncology research in-house. Eventually, a forthcoming version of the kit may result in added resources for clinicians to utilize in the diagnosis and treatment of cancer.
- In January 2021, Roche declared the CE-IVD kick-off of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis, and uPath Dual ISH image analysis for breast cancer to assist in establishing the top treatment strategy for every patient. The image analysis algorithms utilize artificial intelligence to back pathologists in making quicker, more precise patient diagnoses in breast cancer.
Digital PCR (dPCR) and qPCR Market - Forecast(2021 - 2026)
Report Code: HCR 0466
Lateral Flow Assay Market - Forecast(2021 - 2026)
Report Code: HCR 0137
For more Lifesciences and Healthcare Market reports, please click here